Co-existence of and in Acute Myeloid Leukemia: a Case Report

Overview

Journal Blood Res

Publisher Springer Nature

Specialty Hematology

Date 2023 Aug 25

PMID 37621071

Authors

Suji Park

Jae-Ryong Shim

Ji Hyun Lee

Jin-Yeong Han

Affiliations

Soon will be listed here.

Citing Articles

Impact of hypertensive heart disease, risk factors, and age-period-cohort models across 204 nations and regions from 1990 to 2019: a global perspective from the 2019 global burden of disease study.

Gao G, Chen Z, Yan G, Bao M Front Cardiovasc Med. 2024; 11:1417523.

PMID: 39091356 PMC: 11291211. DOI: 10.3389/fcvm.2024.1417523.

A rare presentation of BCR-ABL1 and RUNX1-MECOM rearrangement in a pediatric patient with acute myeloid leukemia.

Alamri R, Alanazi M, AlRajeh R, Tashkandi S, Alswayyed A, Samman M Clin Case Rep. 2024; 12(5):e8917.

PMID: 38751957 PMC: 11093904. DOI: 10.1002/ccr3.8917.

References

Ammatuna E, Divona M, Curzi P, Panetta P, Zaza S, Postorino M . Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia. Cancer Genet Cytogenet. 2009; 195(2):189-91. DOI: 10.1016/j.cancergencyto.2009.08.014. View

Bloomfield C, Lawrence D, Byrd J, Carroll A, Pettenati M, Tantravahi R . Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 1998; 58(18):4173-9. View

Kelly L, Gilliland D . Genetics of myeloid leukemias. Annu Rev Genomics Hum Genet. 2002; 3:179-98. DOI: 10.1146/annurev.genom.3.032802.115046. View

Musani R, Chang H . Coexistence of BCR-ABL1 and RUNX1-RUNX1T1 in a de novo AML. Blood. 2021; 137(20):2853. DOI: 10.1182/blood.2021011517. View

Sag S, Yakut T, Gorukmez O, Gorukmez O, Ture M, Karkucak M . Qualitative and quantitative evaluation of the BCR-ABL fusion gene in chronic myelogenous leukemia by flourescence in situ hybridization and molecular genetic methods. Genet Test Mol Biomarkers. 2015; 19(10):584-8. DOI: 10.1089/gtmb.2015.0056. View

Speck N, Gilliland D . Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002; 2(7):502-13. DOI: 10.1038/nrc840. View

Soupir C, Vergilio J, Dal Cin P, Muzikansky A, Kantarjian H, Jones D . Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol. 2007; 127(4):642-50. DOI: 10.1309/B4NVER1AJJ84CTUU. View

Gupta R, Mittal N, Rahman K, Sharma A, Singh P, Kumar S . Rare BCR-ABL1 transcript in a RUNX1-RUNX1T1-positive de novo acute myeloid leukemia: The chicken and egg tale. Int J Lab Hematol. 2018; 40(2):e24-e27. DOI: 10.1111/ijlh.12779. View

Lundan T, Juvonen V, Mueller M, Mustjoki S, Lakkala T, Kairisto V . Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic.... Haematologica. 2008; 93(2):178-85. DOI: 10.3324/haematol.11910. View

10.

Paietta E, Racevskis J, Bennett J, Neuberg D, Cassileth P, Rowe J . Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia. 1998; 12(12):1881-5. DOI: 10.1038/sj.leu.2401229. View

11.

Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G . The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998; 92(7):2322-33. View

12.

Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz M, Le Beau M . The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-405. DOI: 10.1182/blood-2016-03-643544. View

13.

Bacher U, Haferlach T, Alpermann T, Zenger M, Hochhaus A, Beelen D . Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations. Br J Haematol. 2011; 152(6):713-20. DOI: 10.1111/j.1365-2141.2010.08472.x. View

14.

Arber D, Carter N, Ikle D, Slovak M . Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. Hum Pathol. 2003; 34(5):479-83. DOI: 10.1016/s0046-8177(03)00085-6. View